NW
IDXX icon

NewEdge Wealth’s Idexx Laboratories IDXX Stock Holding History

NewEdge Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
5,843
+112
+2% +$62.8K 0.03% 348
2026
Q1 		$3.22M Sell
5,731
-866
-13% -$555K 0.04% 310
2025
Q4 		$4.46M Buy
6,597
+3,629
+122% +$2.47M 0.05% 253
2025
Q3 		$2.14M Sell
2,968
-880
-23% -$534K 0.03% 384
2025
Q2 		$2.5M Buy
3,848
+3,145
+447% +$1.5M 0.04% 332
2025
Q1 		$295K Buy
703
+85
+14% +$36.9K 0.01% 774
2024
Q4 		$256K Sell
618
-545
-47% -$239K ﹤0.01% 808
2024
Q3 		$588K Buy
1,163
+254
+28% +$123K 0.01% 583
2024
Q2 		$443K Buy
909
+299
+49% +$150K 0.01% 576
2024
Q1 		$290K Sell
610
-49
-7% -$26.8K 0.01% 674
2023
Q4 		$366K Buy
659
+20
+3% +$9.39K 0.01% 573
2023
Q3 		$279K Buy
639
+149
+30% +$74.3K 0.01% 558
2023
Q2 		$246K Sell
490
-21
-4% -$10.1K 0.01% 569
2023
Q1 		$256K Buy
+511
New +$245K 0.01% 536
2022
Q4 		– Sell
-639
Closed -$208K – 557
2022
Q3 		$208K Buy
+639
New +$235K 0.01% 487
2022
Q2 		– Sell
-8,043
Closed -$4.4M – 564
2022
Q1 		$4.4M Buy
8,043
+373
+5% +$196K 0.2% 116
2021
Q4 		$5.05M Buy
7,670
+155
+2% +$97.3K 0.21% 109
2021
Q3 		$4.67M Buy
7,515
+384
+5% +$258K 0.28% 86
2021
Q2 		$4.5M Buy
7,131
+713
+11% +$394K 0.34% 83
2021
Q1 		$3.14M Buy
+6,418
New +$3.22M 0.31% 83

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

NewEdge Wealth's IDXX Position: Q2 2026 in Review

NewEdge Wealth increased its Idexx Laboratories (IDXX) stake by 2% in Q2 2026, buying an estimated $62.8K and bringing the position to 5,843 shares worth $3.08M. The position accounts for 0.03% of the portfolio, ranked #348.

NewEdge Wealth first reported a position in IDXX in Q1 2021 and has held it in 20 quarters since. The position peaked at $5.05M in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • NewEdge Wealth held 5,843 shares of Idexx Laboratories worth $3.08M as of Q2 2026.
  • NewEdge Wealth bought 112 Idexx Laboratories shares in Q2 2026, an estimated $62.8K.
  • Idexx Laboratories made up 0.03% of NewEdge Wealth's portfolio in Q2 2026, its #348 holding.
  • NewEdge Wealth first reported a position in Idexx Laboratories in Q1 2021 and has held it in 20 quarters since.
  • NewEdge Wealth's Idexx Laboratories position peaked at $5.05M in Q4 2021.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.